CINECA IRIS Institutional Research Information System

BIGLIA, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.758
EU - Europa 10.262
AS - Asia 6.066
SA - Sud America 693
OC - Oceania 245
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 25
Totale 32.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.100
CN - Cina 2.904
IT - Italia 2.542
IE - Irlanda 1.114
SG - Singapore 1.008
DE - Germania 976
FR - Francia 890
SE - Svezia 843
GB - Regno Unito 719
FI - Finlandia 612
UA - Ucraina 588
KR - Corea 553
ES - Italia 462
BR - Brasile 402
CA - Canada 389
PL - Polonia 364
TR - Turchia 299
MX - Messico 226
VN - Vietnam 217
JP - Giappone 215
AU - Australia 199
IN - India 166
BE - Belgio 149
NL - Olanda 148
ID - Indonesia 142
RU - Federazione Russa 135
AT - Austria 126
TW - Taiwan 108
GR - Grecia 101
CH - Svizzera 90
PT - Portogallo 88
CO - Colombia 78
HK - Hong Kong 78
CL - Cile 77
RO - Romania 67
AR - Argentina 64
TH - Thailandia 62
IL - Israele 59
IR - Iran 58
DK - Danimarca 53
NZ - Nuova Zelanda 45
MY - Malesia 42
PH - Filippine 39
NO - Norvegia 31
PE - Perù 31
SN - Senegal 28
EG - Egitto 27
EU - Europa 24
SA - Arabia Saudita 23
LT - Lituania 22
ZA - Sudafrica 22
CR - Costa Rica 20
HU - Ungheria 20
CZ - Repubblica Ceca 18
EC - Ecuador 18
PK - Pakistan 18
HR - Croazia 17
SI - Slovenia 16
SK - Slovacchia (Repubblica Slovacca) 16
VE - Venezuela 16
NG - Nigeria 15
JO - Giordania 14
MA - Marocco 14
RS - Serbia 14
TN - Tunisia 13
GT - Guatemala 11
IQ - Iraq 11
BG - Bulgaria 10
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
MU - Mauritius 8
LV - Lettonia 6
LB - Libano 5
PS - Palestinian Territory 5
BD - Bangladesh 4
BY - Bielorussia 4
DZ - Algeria 4
ET - Etiopia 4
KE - Kenya 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MD - Moldavia 4
BO - Bolivia 3
MT - Malta 3
OM - Oman 3
SV - El Salvador 3
UY - Uruguay 3
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
IS - Islanda 2
MC - Monaco 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
UG - Uganda 2
YE - Yemen 2
A1 - Anonimo 1
AL - Albania 1
Totale 32.178
Salva come PNG Salva come JPEG
Città #
Beijing 1.759
Houston 1.489
Chandler 1.273
Dublin 1.094
Santa Clara 922
Singapore 793
Fairfield 578
Jacksonville 460
Villeurbanne 430
Ashburn 419
Medford 417
Princeton 396
Woodbridge 394
Wilmington 378
Redwood City 369
Columbus 312
Torino 297
Ann Arbor 292
Milan 279
Seattle 266
Warsaw 254
Dearborn 213
Nyköping 189
Cambridge 187
Hangzhou 165
Pisa 147
Turin 142
Dong Ket 116
Toronto 116
Rome 107
Guangzhou 99
Jakarta 98
Boardman 92
Verona 91
Vienna 89
Shanghai 87
Istanbul 85
New York 78
Nanjing 77
Tokyo 75
Boston 72
Taipei 68
London 66
Helsinki 63
Madrid 60
Barcelona 59
Fremont 59
Norwalk 56
Santiago 54
São Paulo 51
Munich 49
Bologna 47
San Diego 45
Brussels 44
Seoul 44
Falls Church 42
Lyon 39
Moscow 39
Hefei 38
Paris 38
Naples 35
Jinan 33
Phoenix 33
Hong Kong 32
Nanchang 31
Chengdu 30
Mexico 30
Changsha 29
Lima 29
Montréal 29
Shenyang 29
Sydney 29
Duncan 27
Ankara 26
Athens 26
Buenos Aires 26
Lachine 26
Los Angeles 26
Florence 25
Lisbon 25
Rochester 25
Wuhan 25
Bangkok 24
Melbourne 24
Ottawa 24
Philadelphia 24
Xian 24
Berlin 23
Bogotá 22
Polska 22
Zurich 22
Amsterdam 21
Düsseldorf 21
Padova 21
Zhengzhou 21
Birmingham 20
Durham 20
Kunming 20
Menlo Park 20
Fuzhou 19
Totale 17.175
Salva come PNG Salva come JPEG
Nome #
Breast cancer treatment in mutation carriers - surgical treatment 2.130
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? 1.372
Menopause and hormone replacement therapy. The 2017 recommendations of the Italian Menopause Society 1.350
Clinical profile of women with VVA who are not candidates for local vaginal oestrogen therapy 1.118
Lower Body Lymphedema in Patients with Gynecologic Cancer 776
Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms 700
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 678
Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy 551
Palliative care in patients with ovarian cancer and bowel obstruction 516
Treatment of climacteric symptoms in survivors of gynaecological cancer 506
The Role of Surgery in Recurrent Endometrial Cancer 404
Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection 379
Attitudes on fertility issues in breast cancer patients: An Italian survey 321
Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. 317
Chemoprevention or mastectomy for women at high risk of developing breast cancer 304
Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection 291
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 270
Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Società Italiana per la Menopausa (SIM) and the Società Italiana della Terza Età (SIGiTE) 256
Anatomia della mammella 251
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. 241
Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity? 238
Day surgery management of early breast cancer: Feasibility and psychological outcomes 224
MicroRNA let-7a Modifies the Effect of Self-Renewal Gene HIWI on Patient Survival of Epithelial Ovarian Cancer. 213
LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis 209
Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population 204
An Insulin-like Growth Factor-II Intronic Variant Affects Local DNA Conformation and Ovarian Cancer Survival. 202
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 200
Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer 178
Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: Analysis of prognostic factors and survival 167
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer 164
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 162
Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion 160
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment 159
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study. 157
Effects of conjugated estrogens and transdermal estradiol on lipid metabolism and blood clotting during the treatment of menopausal syndrome. 156
Terapia pulsatile: nuova via o diverso approccio terapeutico? 153
Effetti dei progestinici sul rischio mammario. 147
Maternal and perinatal outcomes in high vs low risk-pregnancies affected by SARS-COV-2 infection (Phase-2): The WAPM (World Association of Perinatal Medicine) working group on COVID-19 146
Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists 135
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 132
Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review 131
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. 127
Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome 127
Post-menopausal breast cancer risk: oral estrogen treatment and abdominal obesity induce opposite changes in possibly important biological variables. 126
HRT and breast cancer risk: a clue for interpreting the available data. 122
[Postoperative infections and antibiotic prophylaxis in radical hysterectomy. Review of the literature] 120
Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values. 116
Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer 114
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey. 113
[Postoperative infections and antibiotic prophylaxis in radical hysterectomy. Retrospective study] 112
Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids 112
Nipple-sparing mastectomy: external validation of a three-dimensional automated method to predict nipple occult tumour involvement on preoperative breast MRI 108
Benign breast disease. An update. 107
REQUISITI ESSENZIALI PER IL TRATTAMENTO DELLE NEOPLASIE GINECOLOGICHE 107
Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: An Uncommon Finding in an Uncommon Patient 107
Progestins and breast cancer risk. 105
Comparison of two models for the prediction of nonsentinel node metastases in breast cancer 105
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: An update 103
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C 102
How to manage the menopause following therapy for breast cancer. Is raloxifene a safe alternative? 101
[Obstetric future of women having undergone cesarean section] 100
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer. 98
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 98
HRT, breast and endometrial cancers: strategies and intervention options. 97
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. 96
Tamoxifen and endometrial cancer. 96
Sonographic Pitfall in Endometriotic Ovarian Cysts: A Rare Case of a Spontaneous Sigmoid Colonic Perforation in a Nonpregnant Woman 96
Current evidence of the oncological benefit-risk profile of hormone replacement therapy 96
Conjugated estrogens and breast cancer risk. 95
Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel 95
ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics 94
The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer. 92
microRNA and cancer progression in Breast Tumours 92
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 92
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C 91
Chemoresistance in breast tumors. 90
Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. 89
Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589. 88
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival 88
Validation of different radioguided techniques for sentinel node localization in breast cancer patients. 88
Transdermal 17- beta-estradiol and conjugated estrogens treatments in postmenopausal bone loss prevention. 88
Le lesioni preneoplastiche della mammella. 88
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial 88
Brevità della vagina e variazione dell'asse vaginale quali fattori predisponenti al prolasso della cupola vaginale dopo colpoisterectomia. 87
Insulin-like growth factor-I and risk of breast cancer. 86
Genitourinary syndrome of menopause in breast cancer survivors: Are we facing new and safe hopes? 85
GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000. 84
Pathological classification of ductal carcinoma in situ of the breast correlates with surgical treatment and may be predicted by mammography 84
Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. 84
Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 84
Identification of new genes associated with breast cancer progression by gene expression analysis of pre-defined sets of neoplastic tissues 83
Annessiectomia profilattica: punto di vista dell'oncologo. 83
Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes 83
Pregnancy after breast cancer 83
Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome 83
Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other risk women) 82
Raloxifene and endometrial cancer. 81
Oral contraceptive use and breast cancer risk in areas with different incidence. A case-control study among young women. 81
Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial 81
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells. 81
Totale 22.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.637
article - articoli 0
book - libri 0
conference - conferenze 14.658
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.045 0 0 0 0 0 1.238 384 267 391 316 255 194
2020/20213.653 438 192 287 293 316 254 221 171 390 374 263 454
2021/20223.161 139 164 191 174 179 107 183 196 169 184 711 764
2022/20234.995 507 198 135 338 543 1.258 395 381 560 120 345 215
2023/20242.462 319 396 162 167 184 198 129 185 29 159 188 346
2024/20253.344 104 432 232 574 1.569 433 0 0 0 0 0 0
Totale 33.333